Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens Tuesday
Tags Business News Novo Nordisk A/S Investing
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Markets Novo Nordisk A/S Europe News
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Business News Health & Science Biotechnology
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Companies US: News Biotechnology
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Health care industry Politics Merck & Co Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Amgen Inc Merck & Co Inc Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Health care industry Eli Lilly and Co Healthy Returns
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags Pharmaceuticals Business Science
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Altimmune Inc Healthy Returns Eli Lilly and Co
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags US: News Companies Biogen Inc
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Roche Holding AG Eli Lilly and Co Business
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Viking Therapeutics Inc
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Biotechnology Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Healthy Returns Johnson & Johnson Health care industry
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Pharmaceuticals Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Science Eli Lilly and Co
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Eli Lilly and Co Health care industry Novo Nordisk A/S
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets stocks Investment Strategy
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Cigna Corp CVS Health Corp Eli Lilly and Co
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Breaking News: Politics Government and politics JPMorgan Chase & Co
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Tesla Inc Stock indices and averages Economic policy
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Wall Street Prescription drug costs Health care industry
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Companies US: News Biotechnology
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags UnitedHealth Group Inc Viking Therapeutics Inc Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Oracle Corp
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.